Trailing-twelve-month (TTM) revenue is $2.01 Billion with a year-over-year growth of +48.46%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $454,225,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q3 FY2026Period ended 2025-12-31 | $586,511,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q4 FY2026Period ended 2026-03-31 | $588,580,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-27 |
| Q1 FY2027Period ended 2026-06-30 | $378,889,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $2,008,205,000 |
Current P/S: $5,826,203,451 market capitalization ÷ $2,008,205,000 TTM revenue = 2.90x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:25:14.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $378.89M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:28:00.645Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Carried Interest Allocation | N/A | N/A | -$122M | N/A | N/A | $708M |
| Carried Interest Allocation, Realized | $63M | $201M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $621M | $937M | $171M | $520M | $654M | $922M |
| UNITED STATES | $167M | $428M | -$238M | $191M |
$2.01B
$2.01 Billion
+48.46%
vs. $1.35B a year ago (TTM)
+11.65%
5 Year compound annual growth rate
1 Year
+48.46%
3 Year
+120.33%
5 Year
+11.65%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $1.99B | +$818.77M | +69.69% |
| 2025 | $1.17B | +$463.20M | +65.09% |
| 2024 | $711.63M | ($653.89M) | (47.89%) |
| 2022 | $1.37B | +$577.81M | +73.35% |
| 2021 | $787.72M | +$341.11M | +76.38% |
| 2020 |
TTM Growth
+48.46%
3-Year CAGR
+120.33%
5-Year CAGR
+11.65%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| N/A |
| Carried Interest Allocation, Unrealized | $434M | $586M | N/A | N/A | N/A | N/A |
|---|
| Incentive Fees | $5M | $12M | $10M | N/A | N/A | $220M |
|---|
| Legacy Carried Interest Allocation | N/A | $187M | -$452M | N/A | N/A | $139M |
|---|
| Management And Advisory Fees, Net | $285M | $380M | $497M | $585M | $767M | $926M |
|---|
| Performance Fees | N/A | N/A | N/A | $126M | $408M | N/A |
|---|
| $1.1B |
| $446.61M |
| +$190.34M |
| +74.27% |
| 2019 | $256.27M | ($8.01M) | (3.03%) |
| 2018 | $264.27M | +$101.22M | +62.07% |
